EE505 Cost-Effectiveness of Ofatumumab in Treatment of Relapsing Multiple Sclerosis in Turkey

The objective of this study is to evaluate the cost-effectiveness of ofatumumab against ocrelizumab and natalizumab for the treatment of Relapsing MS (RMS).

Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: M. Tatar, B. Yarc ı, A.C. Akdemir, Ç Ölmez, F. İğde, E. Tınaz, M. Turanlı Source Type: research